RGMA gene polymorphisms as predictive biomarkers for early relapse in neuromyelitis optica spectrum disorders
RGMA gene polymorphisms, specifically rs725458-CC and rs4778099-AA, are key predictors of early NMOSD relapse. Integrating these markers with clinical data improves relapse risk prediction, enabling more targeted treatment strategies.
Authors
- Renbin Wang
- Jinsong Jiao (ORCID: https://orcid.org/0000-0002-5966-2290)
- Yeqiong Zhang (ORCID: https://orcid.org/0000-0003-2324-8570)
- Xiaoyi Yang (ORCID: https://orcid.org/0000-0001-9428-1445)
- Lei Cui (ORCID: https://orcid.org/0000-0002-7611-1431)
- Dantao Peng (ORCID: https://orcid.org/0000-0001-8038-3192)
- Weihe Zhang (ORCID: https://orcid.org/0009-0008-6392-5664)
Institutions
- China-Japan Friendship Hospital (CN)
Publication Details
- Journal
- Neurobiology of Disease
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1016/j.nbd.2025.107063
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00